Submit your Zyprexa claim details for a free, no obligation case review
Get Started:
Zyprexa heart attack risks may be elevated in patients with a history of heart problems. There is no solid evidence to suggest that Zyprexa use, in and of itself, increases a patient''s risk of suffering a heart attack or some other adverse cardiovascular event, yet patients who have a history of these medical conditions may not be good candidates for Zyprexa treatment.
Zyprexa is an atypical antipsychotic medication that is prescribed to treat schizophrenia and the manic symptoms of bi-polar disorder. Zyprexa is manufactured by Eli Lilly, who enjoys a 2.6 billion dollar profit margin from annual sales of this medication in the United States alone. Zyprexa was approved by the FDA in 1996 and is currently the most widely prescribed medication for treatment of schizophrenia and bipolar mania.
Zyprexa heart attack risks are greater in patients who have a history of heart problems or other physical ailments. Patients with a history of heart disease, high blood pressure, or heart attack are more likely to suffer from extreme low blood pressure, increased heart rate, dizziness, and fainting when taking Zyprexa. These adverse side effects can also occur in Zyprexa users who do not have a history of heart problems, particularly if they become dehydrated.
If you have a history of heart conditions, you may be at an increased risk of suffering a Zyprexa heart attack. It is important to speak with your doctor about your full medical history before initiating a Zyprexa treatment or any other prescription drug. It is also important to tell your doctor about all other medications and supplements you are taking, as some of these may react poorly with Zyprexa.
Zyprexa heart attack risks are also increased when a patient overdoses on this medication. Symptoms of a Zyprexa overdose can include rapid or irregular heart beat, slurred or difficult speech, agitation, drowsiness, and stupor.
If you have concerns about Zyprexa heart attack risks, you may wish to contact your medical professional in order to discuss your concerns in detail.
On March 6, 2008, the State of Alaska provided its opening arguments in a lawsuit against the maker of the schizophrenia drug Zyprexa.
The lawsuit contends that the pharmaceutical giant Eli Lilly played down the diabetes and weight gain The maker of the popular antipsychotic drug Zyprexa is in talks to settle state and federal claims over the company’s marketing practices for more than $1 billion, potentially the... Strong new warnings were added to the label of the top-selling antipsychotic Zyprexa last week, alerting patients and physicians to the increased risk of high blood sugar and » Read More "Makers of Zyprexa may Settle Suit"
"High Blood Sugar and Weight Gain Risks"
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice